What is the main purpose of this Merck 8-K filing?

The main purpose of this 8-K filing by Merck & Co., Inc. is to furnish investors with a document containing Frequently Asked Questions and Answers (FAQs) dated November 14, 2008, which was prepared and issued by Schering-Plough Corporation.

Is the information in the FAQs directly from Merck?

No, the FAQs were issued by Schering-Plough Corporation and are being furnished by Merck & Co., Inc. This suggests the content may be related to Schering-Plough's business or potentially ongoing discussions or events involving both companies.

Where can I find the full FAQ document?

The full FAQ document is available as Exhibit 99.1 to this 8-K filing and is also posted on the Schering-Plough Corporation website under the 'Investor Relations/Investor FAQs' section.

Does Merck plan to update these FAQs?

No, Merck & Co., Inc. explicitly states that it undertakes no obligation to update the FAQs. Investors should pay attention to the date of the information when reviewing these FAQs or other historical data.

MRK 8-K: Regulation FD — Nov 14, 2008

Summary

Merck & Co., Inc. (MRK) filed an 8-K on November 14, 2008, primarily to furnish Exhibit 99.1, which contains Frequently Asked Questions and Answers (FAQs) dated November 14, 2008. The filing indicates that these FAQs were issued by Schering-Plough Corporation and are available on Schering-Plough's investor relations website. Investors should note that Merck is furnishing this document, but it originates from Schering-Plough, suggesting it may relate to prior information or ongoing discussions relevant to Schering-Plough's business. Merck explicitly states no obligation to update these FAQs.

Key Highlights

1Merck & Co., Inc. filed an 8-K on November 14, 2008.
2The primary purpose of the filing is to disclose a 'Frequently Asked Questions and Answers' (FAQ) document.
3The FAQ document is dated November 14, 2008, and is provided as Exhibit 99.1.
4The FAQ document was issued by Schering-Plough Corporation.
5The FAQs are available on Schering-Plough's investor relations website.
6Merck states it undertakes no obligation to update the provided FAQs.